Invention Grant
- Patent Title: Antitumor agent
- Patent Title (中): 抗肿瘤剂
-
Application No.: US13046082Application Date: 2011-03-11
-
Publication No.: US08822422B2Publication Date: 2014-09-02
- Inventor: Yoshinori Naoe , Takeshi Inoue , Yasuhiko Kano
- Applicant: Yoshinori Naoe , Takeshi Inoue , Yasuhiko Kano
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2004-050520 20040225
- Main IPC: A61K38/12
- IPC: A61K38/12 ; A61P35/00 ; C07K7/50 ; A61K31/122 ; A61K45/06 ; A61K31/337
Abstract:
An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
Public/Granted literature
- US20110160295A1 ANTITUMOR AGENT Public/Granted day:2011-06-30
Information query
IPC分类:
